Edition:
United Kingdom

People: AMAG Pharmaceuticals Inc (AMAG.OQ)

AMAG.OQ on NASDAQ Stock Exchange Global Select Market

9.00USD
16 Jul 2019
Change (% chg)

$-0.23 (-2.49%)
Prev Close
$9.23
Open
$9.16
Day's High
$9.22
Day's Low
$8.97
Volume
203,289
Avg. Vol
280,347
52-wk High
$26.08
52-wk Low
$7.81

Deptula, Barbara 

Ms. Barbara H. Deptula is Independent Director of the Company. She served as the Executive Vice President of Business Development and Chief Corporate Development Officer of Shire Plc. (“Shire”), a public biopharmaceutical company, from 2004 to 2012. Prior to joining Shire, Ms. Deptula served as President of the biotechnology division of SICOR, Inc. from 2003 to 2004. Prior to SICOR, Inc., Ms. Deptula served as Senior Vice President for Coley Pharmaceutical Group, Inc. from 2000 to 2003. Prior to 2000, she also held senior management positions in public and private pharmaceutical companies where Ms. Deptula focused on marketing, product development, licensing and business development, including US Bioscience, Inc., Schering Plough International, Lederle Laboratories, a division of American Cyanamid Co., U.S.A., and Genetics Institute. Ms. Deptula holds a B.S. in Pharmacy from the University of Connecticut’s School of Pharmacy and an M.B.A. with a concentration in finance from the University of Chicago Booth School of Business.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD 87,482
Long-Term Incentive Plans, USD --
All Other, USD 153,499
Fiscal Year Total, USD 240,981

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Gino Santini

282,981

William Heiden

4,966,220

Edward Myles

1,537,340

Elizabeth Bolgiano

--

Joseph Vittiglio

1,203,710

J. Alan Butcher

2,083,060
As Of  31 Dec 2018